Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies.
about
Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies?CLIPPERS: chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids. Review of an increasingly recognized entity within the spectrum of inflammatory central nervous system disordersAn update on the use of immunoglobulin for the treatment of immunodeficiency disordersImmunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple SclerosisPatterns of Treatment Switching in Multiple Sclerosis Therapies in US Patients Active on Social Media: Application of Social Media Content Analysis to Health Outcomes Research.Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management.The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.Cerebrospinal Fluid Cytokine Expression Profile in Multiple Sclerosis and Chronic Inflammatory Demyelinating Polyneuropathy.Efficacy of alemtuzumab and natalizumab in the treatment of different stages of multiple sclerosis patients.Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis.
P2860
Q26801349-417214C9-8CC5-4B24-8CB7-281EF3A8926BQ26861050-4DDCC514-75F2-44E8-96FF-F4DE40FE9955Q27012785-999C6FA3-D8DD-4573-BE08-9EFD049C31A1Q36365583-8DBBFF85-3A7D-4F13-980B-C4DA7F797086Q36407218-922265C6-ECCD-4163-8A68-81F002E52930Q36826621-36604431-AC50-4043-AE71-D72CE3CDD69CQ38690022-1E7936CC-5DD4-4BDB-A65F-81584B7BBD5BQ47114458-93493685-58E7-4172-902D-6CBA100B3E92Q47356888-29F7B57C-D3FD-408B-B91A-BD5D38F02B64Q49712050-1EE10A10-E7F2-4107-B7D2-ACD829D0916FQ50437981-F3129E7E-61DC-4E00-97C3-B38C70C5B4D5
P2860
Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Disease-modifying therapy in m ...... current and future strategies.
@en
type
label
Disease-modifying therapy in m ...... current and future strategies.
@en
prefLabel
Disease-modifying therapy in m ...... current and future strategies.
@en
P2860
P356
P1476
Disease-modifying therapy in m ...... current and future strategies.
@en
P2093
P2860
P304
P356
10.1111/CEI.12195
P577
2014-03-01T00:00:00Z